<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Cautious Hold Rating on Sanofi Due to Safety Concerns and Limited Growth Prospects for Qfitlia

PremiumRatings

1d ago

Alnylam announces FDA approval of Qfitlia for treatment of hemophilia A or B

PremiumThe Fly

4d ago

FDA approves Sanofi treatment for hemophilia A or B

ALNY

PremiumThe Fly

4d ago

Biotech Alert: Searches spiking for these stocks today

PremiumThe Fly

4d ago

PTN

PremiumThe FlyRegeneron, Sanofi announce Dupixent authorization in Japan

5d ago

REGN

RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports

The Fly

RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports

6d ago

BMY

U.S. to end funding for child vaccines in developing countries, NY Times reports

The Fly

U.S. to end funding for child vaccines in developing countries, NY Times reports

6d ago

Large pharma M&A deals stalling amid volatile policies, Reuters reports

GSK

PremiumThe Fly

6d ago

Sanofi reports tolebrutinib submission accepted for FDA priority review

BMY

PremiumThe Fly

7d ago

Cantor Fitzgerald calls attention to Alnylam’s Amvuttra’s 30% royalty burden

PremiumThe Fly

7d ago

FedEx downgraded, Adobe upgraded: Wall Street’s top analyst calls

ALNY

PremiumThe Fly

11d ago

AZO

CRL

PremiumThe FlyBanks launch $8.1B debt sale, finance stake in Sanofi unit, Bloomberg says

12d ago

Sanofi initiated with a Neutral at Goldman Sachs

The Fly

Sanofi initiated with a Neutral at Goldman Sachs

12d ago

Sanofi to acquire Dren Bio’s DR-0201; deal includes $600M upfront payment

The Fly

Sanofi to acquire Dren Bio’s DR-0201; deal includes $600M upfront payment

13d ago

Trump Trade: Administration explores simplified plans for reciprocal tariffs

PremiumThe Fly

14d ago

PremiumThe Fly

Big pharma fears drug price spikes in US-EU tariff spat, Reuters says

15d ago

Sanofi starts annual production of vaccines for 2025-26 flu season

BMY

PremiumThe Fly

18d ago

Regeneron, Sanofi presents results from ADEPT Phase 2/3 trial on Dupixent

PremiumThe Fly

23d ago

REGN

PremiumThe FlyCDC plans study into potential vaccines, autism connections, Reuters reports

25d ago

JNJ

MRK

Sanofi’s Growth Potential Driven by Amlitelimab’s Promising Outlook and Strategic Focus

Ratings

Sanofi’s Growth Potential Driven by Amlitelimab’s Promising Outlook and Strategic Focus

26d ago

Sanofi price target raised to EUR 120 from EUR 115 at Berenberg

The Fly

Sanofi price target raised to EUR 120 from EUR 115 at Berenberg

27d ago